• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by GoHealth Inc.

    5/16/25 5:02:44 PM ET
    $GOCO
    Specialty Insurers
    Finance
    Get the next $GOCO alert in real time by email
    NT 10-Q 1 goco-nt10xqq12025.htm NT 10-Q Document


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     
    FORM 12b-25
     
     
    NOTIFICATION OF LATE FILING

    (Check one):  
    ☐ Form 10-K  ☐ Form 20-F  ☐ Form 11-K  ☒ Form 10-Q
    ☐ Form 10-D  ☐ Form N-CEN  ☐ Form N-CSR
     For Period Ended: March 31, 2025
     
    ☐ Transition Report on Form 10-K
     
    ☐ Transition Report on Form 20-F
     
    ☐ Transition Report on Form 11-K
     
    ☐ Transition Report on Form 10-Q
     For the Transition Period Ended:  
    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: Not Applicable
     
     
    PART I — REGISTRANT INFORMATION
    GOHEALTH, INC.
    Full Name of Registrant
    Not Applicable
    Former Name if Applicable
    222 W Merchandise Mart, Suite 1750
    Address of Principal Executive Office (Street and Number)
    Chicago, Illinois 60654
    City, State and Zip Code




    PART II — RULES 12b-25(b) AND (c)
    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
     
    ☒ (a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
     (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
     (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.



    PART III — NARRATIVE
    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
    The Quarterly Report on Form 10-Q for the three months ended March 31, 2025 (the “Quarterly Report”) of GoHealth, Inc. (the “Company”) could not be filed with the Securities and Exchange Commission within the prescribed time period without unreasonable effort or expense. The delay in filing is necessary to allow adequate time for management to perform its review and assessment of certain financial and other related data and the disclosures required in connection therewith, as described in further detail in the paragraphs below.
    As of March 31, 2025, the Company is in compliance with all of its financial covenants contained in its credit facilities. However, management’s current financial projections indicate that, based on the Company’s current business plan, there is a significant likelihood that the Company will be unable to maintain compliance with its covenants and make scheduled principal and interest payments, including amounts due under the Class A Revolving Facility expiring on June 30, 2025, within the twelve months after the date the Quarterly Report is filed, unless the mitigating plans described below are implemented successfully. If the Company is unable to meet its covenants or make scheduled principal and interest payments, the Company’s lenders could declare the Company in default and accelerate all amounts owing under the credit facilities. The Company does not expect it would have sufficient liquidity to repay such amounts. Management has developed mitigating plans to address the potential liquidity constraints, including cost control measures and renegotiation of the terms of its existing debt arrangements. However, the Company cannot provide assurance that it will be successful in implementing these mitigating plans on acceptable terms, if at all. As a result, there is substantial doubt about the Company’s ability to continue as a going concern.
    The significant additional time required to evaluate the effects of and disclose, in compliance with the requirements of Form 10-Q, the concerns regarding the Company’s compliance with the covenants under its credit facilities, potential defaults and events of default thereunder and the going concern of the Company has resulted in the Company being unable to file the Quarterly Report within the prescribed time period without unreasonable effort or expense.
    The Quarterly Report was filed on May 16, 2025 prior to the filing of this Form 12b-25.




    PART IV — OTHER INFORMATION
     
    (1) 
    Name and telephone number of person to contact in regard to this notification
     Brendan Shanahan 312 386-8200
     (Name)(Area Code) (Telephone Number)
    (2) 
    Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).  Yes ☒ No ☐
    (3) 
    Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?  Yes ☒ No ☐
     
    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

    For a comparison of the Company’s results of operations for the three months ended March 31, 2025 compared to the three months ended March 31, 2024, please see the Form 10-Q filed with the Securities and Exchange Commission on May 16, 2025 prior to this Form 12b-25.
    CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
    This Form 12b-25 contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements are made in reliance upon the safe harbor provision of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this Form 12b-25 may be forward-looking statements. Statements regarding our future results of operations and financial position, business strategy and plans and objectives of management for future operations, including, among others, statements regarding our expected growth, future capital expenditures, debt service obligations, ability to continue as a going concern, adoption and use of artificial intelligence technologies, the impact on our business from regulatory changes, the impact on our business from the acquisition of e-TeleQuote Insurance, Inc. (“e-TeleQuote”) and our ability to successfully integrate e-TeleQuote’s operations, technologies and employees into our business, are forward-looking statements.
    In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “aims,” “expects,” “plans,” “anticipates,” “could,” “intends,” “targets,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” “likely,” “future” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this Form 12b-25 are only predictions, projections and other statements about future events that are based on current expectations and assumptions. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions and uncertainties that are difficult to predict. Although we believe that the expectations reflected in these forward-looking statements are reasonable as of the date made, actual results may prove to be materially different from the results expressed or implied by the forward-looking statements.
    These forward-looking statements speak only as of the date of this Form 12b-25 and are subject to a number of important factors that could cause actual results to differ materially from those in the forward-looking statements, including the factors described in the sections titled “Summary Risk Factors,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended December 31, our Quarterly Report on Form 10-Q for the first quarter ended March 31, 2025, and in our other filings with the Securities and Exchange Commission.



    You should read this Form 12b-25 and the documents that we reference in this Form 12b-25 completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

     
    GoHealth, Inc.
    (Name of Registrant as Specified in Charter)
    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
     
    Date: May 16, 2025  By: /s/ Brendan Shanahan
       Brendan Shanahan
       Chief Financial Officer
      



    Get the next $GOCO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GOCO

    DatePrice TargetRatingAnalyst
    4/1/2022$1.50Underperform
    Credit Suisse
    3/3/2022$10.00 → $2.00Outperform → Sector Perform
    RBC Capital
    3/2/2022Buy → Hold
    Truist
    3/2/2022$2.00Buy → Hold
    Truist Securities
    1/7/2022$6.00 → $3.00Neutral → Underperform
    Credit Suisse
    1/5/2022$7.50 → $3.50Buy → Underperform
    B of A Securities
    11/15/2021$7.00 → $6.00Neutral
    Credit Suisse
    11/11/2021$13.00 → $5.50Equal-Weight
    Morgan Stanley
    More analyst ratings

    $GOCO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Kotte Vijay bought $100,275 worth of shares (7,500 units at $13.37), increasing direct ownership by 1% to 653,630 units (SEC Form 4)

      4 - GoHealth, Inc. (0001808220) (Issuer)

      11/15/23 10:10:34 AM ET
      $GOCO
      Specialty Insurers
      Finance

    $GOCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Legal Officer Burd Brad covered exercise/tax liability with 814 shares, decreasing direct ownership by 0.52% to 157,070 units (SEC Form 4)

      4 - GoHealth, Inc. (0001808220) (Issuer)

      5/7/25 2:04:59 PM ET
      $GOCO
      Specialty Insurers
      Finance
    • Chief Executive Officer Kotte Vijay covered exercise/tax liability with 24,612 shares, decreasing direct ownership by 2% to 1,221,491 units (SEC Form 4)

      4 - GoHealth, Inc. (0001808220) (Issuer)

      4/14/25 1:50:52 PM ET
      $GOCO
      Specialty Insurers
      Finance
    • Chief Executive Officer Kotte Vijay was granted 500,000 shares and covered exercise/tax liability with 221,500 shares, increasing direct ownership by 29% to 1,246,103 units (SEC Form 4)

      4 - GoHealth, Inc. (0001808220) (Issuer)

      4/7/25 4:40:00 PM ET
      $GOCO
      Specialty Insurers
      Finance

    $GOCO
    SEC Filings

    See more
    • GoHealth Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - GoHealth, Inc. (0001808220) (Filer)

      6/20/25 1:43:16 PM ET
      $GOCO
      Specialty Insurers
      Finance
    • SEC Form NT 10-Q filed by GoHealth Inc.

      NT 10-Q - GoHealth, Inc. (0001808220) (Filer)

      5/16/25 5:02:44 PM ET
      $GOCO
      Specialty Insurers
      Finance
    • SEC Form 10-Q filed by GoHealth Inc.

      10-Q - GoHealth, Inc. (0001808220) (Filer)

      5/16/25 5:01:07 PM ET
      $GOCO
      Specialty Insurers
      Finance

    $GOCO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Credit Suisse resumed coverage on GoHealth with a new price target

      Credit Suisse resumed coverage of GoHealth with a rating of Underperform and set a new price target of $1.50

      4/1/22 7:10:27 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • GoHealth downgraded by RBC Capital with a new price target

      RBC Capital downgraded GoHealth from Outperform to Sector Perform and set a new price target of $2.00 from $10.00 previously

      3/3/22 4:36:13 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • GoHealth downgraded by Truist

      Truist downgraded GoHealth from Buy to Hold

      3/2/22 7:31:46 AM ET
      $GOCO
      Specialty Insurers
      Finance

    $GOCO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • GoHealth Reports First Quarter 2025 Results

      CHICAGO, May 13, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three months ended March 31, 2025. First Quarter Highlights First quarter 2025 net revenues of $221.0 million, a 19.1% increase compared to $185.6 million in the prior year period.First quarter 2025 net loss of $9.8 million, a 54.2% improvement compared to a net loss of $21.3 million in the prior year period.First quarter 2025 Adjusted EBITDA1 of $42.1 million, a 56.4% increase compared to $26.9 million in the prior year period.First quarter 2025 Submissions2 were

      5/13/25 7:00:00 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • GoHealth's Statement on Recent Allegations in the United States False Claims Act Complaint

      CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, firmly denies the allegations made by the Government in a lawsuit in which the company has been named as a defendant related to events that allegedly occurred between 2016 and 2021. We are disappointed that the Government is pursuing claims against a company that has at all times worked to advance the interests of the Medicare Advantage program and the Medicare beneficiaries it serves. GoHealth maintains that it complied with the laws that were specifically designed by Congress and HHS to address payments by Medicare Advanta

      5/7/25 8:00:00 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • GoHealth to Announce First Quarter 2025 Results on May 13, 2025

      CHICAGO, May 05, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced that the company will release its first quarter 2025 financial results on the morning of May 13, 2025. Chief Executive Officer, Vijay Kotte, and Chief Financial Officer, Brendan Shanahan, will host a conference call and live audio webcast on the day of the release at 8:00 a.m. (ET) to discuss the results. A live audio webcast of the conference call will be available via GoHealth's Investor Relations website, https://investors.gohealth.com/. A replay of the call will be available via webcast for on-demand listening

      5/5/25 9:00:00 AM ET
      $GOCO
      Specialty Insurers
      Finance

    $GOCO
    Leadership Updates

    Live Leadership Updates

    See more
    • Brendan Shanahan Appointed Chief Financial Officer of GoHealth, Bringing Decades of Leadership in Healthcare and Financial Strategy

      CHICAGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced the appointment of Brendan Shanahan as Chief Financial Officer (CFO), effective October 14, following a comprehensive search process. Mr. Shanahan, a seasoned executive with over 30 years of financial leadership experience and over 20 years of expertise in the Medicare Advantage space, will oversee GoHealth's financial strategy and operations, contributing to the company's profitable growth and innovation efforts. "Brendan's extensive expertise in financial strategy, M&A, operational leadership, and deep knowledge of t

      10/10/24 9:00:00 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • GoHealth Appoints Vance Johnston as Chief Financial Officer

      CHICAGO, Dec. 6, 2021 /PRNewswire/ -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced today that Vance Johnston will join the Company as Chief Financial Officer (CFO) on December 7, 2021.  As previously announced, Travis Matthiesen, the Company's current CFO, will transition to the role of Chief Transformation Officer and will work closely with Johnston to ensure a smooth transition. "We are very pleased that Vance will be joining the GoHealth executive team as CFO," said Clint Jones, co-fou

      12/6/21 4:05:00 PM ET
      $GOCO
      Specialty Insurers
      Finance
    • GoHealth Appoints Dr. Paul Hain, M.D. as Chief Medical Officer

      CHICAGO, Dec. 1, 2020 /PRNewswire/ -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace, announced today that Dr. Paul Hain, M.D. has joined the company as Chief Medical Officer. In this newly created role, Dr. Hain will work side-by-side with GoHealth's growing TeleCare team, directly building clinical functions within the recently developed Encompass Platform, a digital health solution that provides strategic value to GoHealth members and enterprise partners. Dr. Hain will focus on key member touchpoints including care management and navigation, provider and value-based care engagement, pharmacy engagement, health risk assessments, social determinant of he

      12/1/20 8:06:00 AM ET
      $GOCO
      Specialty Insurers
      Finance

    $GOCO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

      SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

      8/25/23 6:15:20 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

      SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

      8/25/23 6:03:57 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

      SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

      5/19/23 6:08:49 AM ET
      $GOCO
      Specialty Insurers
      Finance

    $GOCO
    Financials

    Live finance-specific insights

    See more
    • GoHealth Reports First Quarter 2025 Results

      CHICAGO, May 13, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three months ended March 31, 2025. First Quarter Highlights First quarter 2025 net revenues of $221.0 million, a 19.1% increase compared to $185.6 million in the prior year period.First quarter 2025 net loss of $9.8 million, a 54.2% improvement compared to a net loss of $21.3 million in the prior year period.First quarter 2025 Adjusted EBITDA1 of $42.1 million, a 56.4% increase compared to $26.9 million in the prior year period.First quarter 2025 Submissions2 were

      5/13/25 7:00:00 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • GoHealth to Announce First Quarter 2025 Results on May 13, 2025

      CHICAGO, May 05, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced that the company will release its first quarter 2025 financial results on the morning of May 13, 2025. Chief Executive Officer, Vijay Kotte, and Chief Financial Officer, Brendan Shanahan, will host a conference call and live audio webcast on the day of the release at 8:00 a.m. (ET) to discuss the results. A live audio webcast of the conference call will be available via GoHealth's Investor Relations website, https://investors.gohealth.com/. A replay of the call will be available via webcast for on-demand listening

      5/5/25 9:00:00 AM ET
      $GOCO
      Specialty Insurers
      Finance
    • GoHealth Reports Strong Fourth Quarter and Fiscal Year 2024 Results, Driven by a Successful Annual Enrollment Period

      CHICAGO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three and twelve months ended December 31, 2024. Fourth Quarter Highlights Achieved net revenues of $389.1 million, a substantial 41% increase compared to the prior year period. Submissions grew to 481,445, representing a 67% increase compared to the prior year period. Net income of $58.0 million, a substantial improvement of $60.3 million compared to the prior year period. Adjusted EBITDA1 surged to $117.8 million, a significant 107% increase compared to the

      2/27/25 7:00:36 AM ET
      $GOCO
      Specialty Insurers
      Finance